Vanguard Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Vanguard Capital Management's ANIP Position: Q3 2026 in Review
Vanguard Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 7.9% in Q3 2026, buying an estimated $5.12M and bringing the position to 904,707 shares worth $65.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.
Vanguard Capital Management first reported a position in ANIP in Q1 2026 and has held it in 3 quarters since. The position peaked at $69.4M in Q2 2026. 289 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Vanguard Capital Management held 904,707 shares of ANI Pharmaceuticals worth $65.7M as of Q3 2026.
- Vanguard Capital Management bought 66,483 ANI Pharmaceuticals shares in Q3 2026, an estimated $5.12M.
- ANI Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1762 holding.
- Vanguard Capital Management first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's ANI Pharmaceuticals position peaked at $69.4M in Q2 2026.
- 289 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.